Cargando…
RF19 | PSUN383 Potential Role of Activin A During Pancreatic Acinar-to-Ductal Metaplasia of Orthotopic Pancreatic Tumor Mice
Pancreatic ductal adenocarcinoma (PDAC) comprises more than 90% of pancreatic cancer cases and commonly harbors mutations in KRAS and TP53. PDAC is the third leading cause of cancer-related deaths in the US with approximately 10% 5-year relative survival rate. The poor survival rate largely pertains...
Autores principales: | Elesh, Ibrahim F, Kim, So-Youn, Luan, Yi, Oupicky, David, Tang, Siyuan, Yu, Seok-Yeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629242/ http://dx.doi.org/10.1210/jendso/bvac150.1863 |
Ejemplares similares
-
Uncovering Tumor‐Promoting Roles of Activin A in Pancreatic Ductal Adenocarcinoma
por: Yu, Seok‐Yeong, et al.
Publicado: (2023) -
THU507 Tumor Activin A Mediates Cachexia Primarily Through White Adipose Tissue Hydrolysis In Pancreatic Ductal Adenocarcinoma
por: Yu, Seok-Yeong, et al.
Publicado: (2023) -
Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias
por: Hong, Seung-Mo, et al.
Publicado: (2010) -
Pharmacological inhibition and reversal of pancreatic acinar ductal metaplasia
por: da Silva, Lais, et al.
Publicado: (2022) -
Transcriptional Profile of Human Pancreatic Acinar Ductal Metaplasia
por: Jiang, Jinmai, et al.
Publicado: (2023)